Wake Research to Attend the Drug Information Associations (DIA) 2017 Annual Meeting

Friday, June 9, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Meet a Growing Company Connecting the Pharma Industry to our Integrated Clinical Research Sites

RALEIGH, N.C., June 9, 2017 /PRNewswire/ -- Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces

the attendance of the 2017 Drug Information Associations (DIA) 53rd Annual Meeting in Chicago, IL from June 18th-21st. Located at booth 1259, Wake Research is proud to be one of the more than 450 exhibiting companies participating in the largest, longest-running event in the life sciences industry.

Wake's team in attendance includes: Ben Riedlinger, Associate Director of Business Development; Marion Peoples, Director Site Start-Up; McKenzie Finch, Business Development Associate; and Brennan Opanasenko, Site Start-Up Associate.

About Wake Research

Wake Research is an organization of unified investigational sites, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. Wake Research is fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications. Founded in 1984, Wake Research has more than 2,500 successful clinical trials and a combined subject database of nearly 950,000 individuals.

Wake Research is a unique and innovative resource, using the talents of 56 Principal Investigators for Phase I through Phase IV clinical trials specializing in gastroenterology, musculoskeletal disorders, metabolic disorders, dermatology, vaccines including bio-defense research, CNS/sleep disorders.

Wake Research is known for effectively combining strategic volunteer recruitment and retention with high quality clinical trial conduct, using centralized administration and standardized operating procedures

About the DIA

DIA, founded as the Drug Information Association, provides a global, neutral forum where stakeholders can openly and freely exchange knowledge information and insights beyond boundaries to advance innovation in health care product development and life cycle management globally.

The DIA Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. Themed "Driving Insights to Action," DIA 2017 will host more than 7,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe. DIA 2017 boasts more than 450 exhibiting companies, 10+ tracks, and more than 160 sessions.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wake-research-to-attend-the-drug-information-associations-dia-2017-annual-meeting-300471392.html

SOURCE Wake Research



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook